Whitney Ijem
Stock Analyst
(n/a)
# 4,648
Out of 4,648 analysts
71
Total ratings
n/a
Success rate
n/a
Average return
Main Sectors:
Top Industries:
Stocks Rated by Whitney Ijem
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ALNY Alnylam Pharmaceuticals | Maintains: Buy | $366 → $384 | $273.91 | +40.19% | 6 | Nov 1, 2024 | |
| BMRN BioMarin Pharmaceutical | Maintains: Hold | $93 → $84 | $66.60 | +26.13% | 8 | Oct 30, 2024 | |
| TNYA Tenaya Therapeutics | Maintains: Buy | $16 | $1.94 | +724.74% | 5 | Oct 18, 2024 | |
| RCKT Rocket Pharmaceuticals | Maintains: Buy | $38 | $16.98 | +123.79% | 4 | Sep 30, 2024 | |
| TSHA Taysha Gene Therapies | Maintains: Buy | $7 → $6 | $1.53 | +292.16% | 7 | Aug 14, 2024 | |
| VERV Verve Therapeutics | Maintains: Buy | $30 → $29 | $5.93 | +389.04% | 3 | Aug 12, 2024 | |
| VRTX Vertex Pharmaceuticals | Maintains: Sell | $371 → $376 | $471.12 | -20.19% | 6 | Jul 31, 2024 | |
| RARE Ultragenyx Pharmaceutical | Maintains: Buy | $111 | $50.99 | +117.69% | 5 | Jul 23, 2024 | |
| NTLA Intellia Therapeutics | Maintains: Buy | $73 | $14.81 | +392.91% | 4 | Jun 27, 2024 | |
| RGLS Regulus Therapeutics | Maintains: Buy | $11 → $28 | $1.49 | +1,779.19% | 4 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $13 | $0.63 | +1,965.46% | 3 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $87 → $86 | $18.00 | +377.78% | 4 | May 10, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $79 | $49.01 | +61.19% | 3 | May 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $2.21 | +307.24% | 1 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $123.29 | - | 2 | Sep 15, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $89.51 | - | 2 | Jan 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $8 → $16 | $0.90 | +1,671.48% | 4 | Jul 23, 2019 |
Alnylam Pharmaceuticals
Nov 1, 2024
Maintains: Buy
Price Target: $366 → $384
Current: $273.91
Upside: +40.19%
BioMarin Pharmaceutical
Oct 30, 2024
Maintains: Hold
Price Target: $93 → $84
Current: $66.60
Upside: +26.13%
Tenaya Therapeutics
Oct 18, 2024
Maintains: Buy
Price Target: $16
Current: $1.94
Upside: +724.74%
Rocket Pharmaceuticals
Sep 30, 2024
Maintains: Buy
Price Target: $38
Current: $16.98
Upside: +123.79%
Taysha Gene Therapies
Aug 14, 2024
Maintains: Buy
Price Target: $7 → $6
Current: $1.53
Upside: +292.16%
Verve Therapeutics
Aug 12, 2024
Maintains: Buy
Price Target: $30 → $29
Current: $5.93
Upside: +389.04%
Vertex Pharmaceuticals
Jul 31, 2024
Maintains: Sell
Price Target: $371 → $376
Current: $471.12
Upside: -20.19%
Ultragenyx Pharmaceutical
Jul 23, 2024
Maintains: Buy
Price Target: $111
Current: $50.99
Upside: +117.69%
Intellia Therapeutics
Jun 27, 2024
Maintains: Buy
Price Target: $73
Current: $14.81
Upside: +392.91%
Regulus Therapeutics
Jun 25, 2024
Maintains: Buy
Price Target: $11 → $28
Current: $1.49
Upside: +1,779.19%
May 15, 2024
Maintains: Buy
Price Target: $14 → $13
Current: $0.63
Upside: +1,965.46%
May 10, 2024
Maintains: Buy
Price Target: $87 → $86
Current: $18.00
Upside: +377.78%
May 8, 2024
Maintains: Buy
Price Target: $80 → $79
Current: $49.01
Upside: +61.19%
Nov 8, 2022
Initiates: Buy
Price Target: $9
Current: $2.21
Upside: +307.24%
Sep 15, 2021
Upgrades: Buy
Price Target: n/a
Current: $123.29
Upside: -
Jan 21, 2020
Downgrades: Neutral
Price Target: n/a
Current: $89.51
Upside: -
Jul 23, 2019
Upgrades: Overweight
Price Target: $8 → $16
Current: $0.90
Upside: +1,671.48%